HU217326B - Mutáns humán interleukin-4 proteinek, azokat tartalmazó gyógyászati készítmények, valamint eljárás a proteinek előállítására - Google Patents

Mutáns humán interleukin-4 proteinek, azokat tartalmazó gyógyászati készítmények, valamint eljárás a proteinek előállítására Download PDF

Info

Publication number
HU217326B
HU217326B HU9401369A HU9401369A HU217326B HU 217326 B HU217326 B HU 217326B HU 9401369 A HU9401369 A HU 9401369A HU 9401369 A HU9401369 A HU 9401369A HU 217326 B HU217326 B HU 217326B
Authority
HU
Hungary
Prior art keywords
human interleukin
replaced
amino acid
mutant human
region
Prior art date
Application number
HU9401369A
Other languages
English (en)
Hungarian (hu)
Other versions
HUT66826A (en
HU9401369D0 (en
Inventor
Walter Sebald
Original Assignee
Bayer Ag.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6444719&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HU217326(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Ag. filed Critical Bayer Ag.
Publication of HU9401369D0 publication Critical patent/HU9401369D0/hu
Publication of HUT66826A publication Critical patent/HUT66826A/hu
Publication of HU217326B publication Critical patent/HU217326B/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5406—IL-4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
HU9401369A 1991-11-13 1992-11-13 Mutáns humán interleukin-4 proteinek, azokat tartalmazó gyógyászati készítmények, valamint eljárás a proteinek előállítására HU217326B (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4137333A DE4137333A1 (de) 1991-11-13 1991-11-13 Therapeutische mittel, die antagonisten oder partielle agonisten des humanen interleukin 4 sind oder diese enthalten, hil-4-mutantenproteine sowie vefahren zu deren herstellung

Publications (3)

Publication Number Publication Date
HU9401369D0 HU9401369D0 (en) 1994-08-29
HUT66826A HUT66826A (en) 1995-01-30
HU217326B true HU217326B (hu) 1999-12-28

Family

ID=6444719

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9401369A HU217326B (hu) 1991-11-13 1992-11-13 Mutáns humán interleukin-4 proteinek, azokat tartalmazó gyógyászati készítmények, valamint eljárás a proteinek előállítására

Country Status (16)

Country Link
US (1) US5723118A (de)
EP (1) EP0613499B2 (de)
JP (2) JP3470970B2 (de)
KR (1) KR100276410B1 (de)
AT (1) ATE163196T1 (de)
AU (1) AU671960B2 (de)
CA (1) CA2123315C (de)
CZ (1) CZ283467B6 (de)
DE (2) DE4137333A1 (de)
DK (1) DK0613499T4 (de)
ES (1) ES2112340T5 (de)
GR (1) GR3026600T3 (de)
HU (1) HU217326B (de)
NO (1) NO312707B1 (de)
SK (1) SK280114B6 (de)
WO (1) WO1993010235A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4423131A1 (de) * 1994-07-01 1996-01-04 Bayer Ag Neue hIL-4-Mutantenproteine als Antagonisten oder partielle Agonisten des humanen Interleukin 4
HUT76369A (en) * 1994-07-29 1997-08-28 Smithkline Beecham Corp Novel soluble protein compounds
GB9415379D0 (en) * 1994-07-29 1994-09-21 Smithkline Beecham Plc Novel compounds
US5986059A (en) * 1996-06-14 1999-11-16 Bayer Corporation T-cell selective interleukin-4 agonists
US6335426B1 (en) 1996-06-14 2002-01-01 Bayer Corporation T-cell selective interleukin-4 agonists
CA2256459A1 (en) * 1996-06-14 1997-12-18 Bayer Corporation T-cell selective interleukin-4 agonists
MY124565A (en) * 1996-07-19 2006-06-30 Bayer Corp High-affinity interleukin-4-muteins
US6180108B1 (en) * 1998-12-10 2001-01-30 Bayer Corporation Vectors having terminal repeat sequence of Epstein-Barr virus
DE10022258A1 (de) 2000-05-08 2001-11-15 Bayer Ag Reinigung von Proteineinschlusskörpern durch Querstrom-Mikrofiltration
DE16192152T1 (de) 2000-05-26 2020-08-06 Immunex Corporation Verwendung von interleukin-4 rezeptor (il-4r) antikörpern und zusammensetzungen davon
GB0105360D0 (en) * 2001-03-03 2001-04-18 Glaxo Group Ltd Chimaeric immunogens
EP1314739A1 (de) * 2001-11-22 2003-05-28 Bayer Ag Verfahren zur Renaturierung rekombinanter, Disulfid-enthaltender Proteine bei hohen Proteinkonzentrationen in Gegenwart von Aminen
EP1382614A1 (de) * 2002-07-15 2004-01-21 Bayer HealthCare AG Verfahren zur Reinigung von Interleukin-4 und seinen Muteinen
US7635754B2 (en) * 2004-09-22 2009-12-22 Aerovance, Inc. Interleukin-9 and interleukin-4 chimeric antagonist muteins and methods of using same
US20070009479A1 (en) * 2005-06-17 2007-01-11 Aerovance, Inc. Methods for treating dermatitis using mutant human IL-4 compositions
BRPI0713484A2 (pt) * 2006-06-21 2012-11-06 Apogenix Gmbh expressão diferencial de citocina em cáncer humano
AU2007271349A1 (en) * 2006-07-06 2008-01-10 Apogenix Gmbh Human IL-4 muteins in combination with chemotherapeutics or pro-apoptotic agents in cancer therapy
EP2596802A1 (de) 2011-11-23 2013-05-29 PLS-Design GmbH Pharmazeutische Zusammensetzung zur Behandlung allergischer Reaktionen
EP2674168A1 (de) 2012-06-14 2013-12-18 PLS-Design GmbH Modulation von Effektor-T-Zell-Antworten durch lokale Depletion des Komplement-Faktors C3

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5041381A (en) * 1986-07-03 1991-08-20 Schering Corporation Monoclonal antibodies against human interleukin-4 and hybridomas producing the same
US5017691A (en) * 1986-07-03 1991-05-21 Schering Corporation Mammalian interleukin-4
ES2058490T3 (es) * 1988-02-02 1994-11-01 Schering Biotech Corp Metodo de reducir respuestas de inmunoglobulina e.
US5188827A (en) * 1989-12-18 1993-02-23 Schering Corporation Use of interleukin-4- for lowering blood-cholesterol levels

Also Published As

Publication number Publication date
HUT66826A (en) 1995-01-30
DK0613499T4 (da) 2005-04-18
AU2928292A (en) 1993-06-15
GR3026600T3 (en) 1998-07-31
CZ283467B6 (cs) 1998-04-15
CZ118594A3 (en) 1994-12-15
CA2123315A1 (en) 1993-05-27
NO941681L (no) 1994-05-06
NO941681D0 (no) 1994-05-06
JPH07501522A (ja) 1995-02-16
EP0613499B1 (de) 1998-02-11
SK280114B6 (sk) 1999-08-06
ES2112340T5 (es) 2005-10-16
JP3470970B2 (ja) 2003-11-25
CA2123315C (en) 2003-06-17
DE59209196D1 (de) 1998-03-19
HU9401369D0 (en) 1994-08-29
SK55494A3 (en) 1994-12-07
ATE163196T1 (de) 1998-02-15
JP2003174894A (ja) 2003-06-24
US5723118A (en) 1998-03-03
EP0613499A1 (de) 1994-09-07
WO1993010235A1 (de) 1993-05-27
DE4137333A1 (de) 1993-05-19
KR100276410B1 (ko) 2000-12-15
NO312707B1 (no) 2002-06-24
DK0613499T3 (da) 1998-09-23
EP0613499B2 (de) 2005-03-30
ES2112340T3 (es) 1998-04-01
AU671960B2 (en) 1996-09-19

Similar Documents

Publication Publication Date Title
HU217326B (hu) Mutáns humán interleukin-4 proteinek, azokat tartalmazó gyógyászati készítmények, valamint eljárás a proteinek előállítására
JP4423313B2 (ja) ナチュラルキラー刺激因子
AU638430B2 (en) Natural killer stimulatory factor
WO1994004680A9 (en) Human interleukin-13
WO1994004680A1 (en) Human interleukin-13
CZ25697A3 (en) Novel compounds
JPH0753594A (ja) インターロイキン−１２のｐ４０ホモダイマー
US7122633B2 (en) Natural killer stimulatory factor
US7026445B2 (en) Human SDF-5 protein and compositions
Takahashi et al. Structural comparison of murine T-cell (B151K12)-derived T-cell-replacing factor (IL-5) with rIL-5: dimer formation is essential for the expression of biological activity
Lillquist et al. Structure-activity studies of human IL-1 beta with mature and truncated proteins expressed in Escherichia coli.
US6537781B1 (en) Methods and compositions concerning canine interleukin 5
JP3652365B6 (ja) ナチュラルキラー刺激因子
CA2348431A1 (en) Interleukin-1 homolog zil1a4
Allison The interleukin‐1 family of molecules
IE990006A1 (en) Cytotoxic Lymphocyte Maturation Factor

Legal Events

Date Code Title Description
GB9A Succession in title

Owner name: BAYER SCHERING PHARMA AG, DE

Free format text: FORMER OWNER(S): BAYER AG., DE